WeVote
Log In

Bill

Bill

SB 575

AN ACT EXPANDING A BIOSCIENCE ENTERPRISE CORRIDOR ZONE LOCATED IN THE TOWN OF PLAINVILLE.

2025 Regular Session

Connecticut expands Plainville's bioscience enterprise zone to attract biotech companies through economic development incentives.

HOUSE CALENDAR NUMBER 680
#bioscience #enterprisecorridorzones #plainville
0
WeVote Research Nonpartisan
Bill Summary · SB 575

Legislative bill overview

SB 575 expands the boundaries and scope of an existing bioscience enterprise corridor zone in Plainville, Connecticut. The expansion aims to attract biotechnology and life sciences companies to the designated area through tax incentives, regulatory relief, or other economic development benefits already established in the original zone.

Why is this important

Enterprise zones are designed to stimulate economic development and job creation in targeted geographic areas. Expanding Plainville's bioscience corridor could increase employment opportunities, property tax revenue, and business investment in that region, particularly in the high-value biotechnology sector.

Potential points of contention

  • Tax revenue trade-offs: Tax incentives offered to zone businesses may reduce municipal revenue in the short term, raising questions about fiscal sustainability and whether benefits justify the cost
  • Geographic equity: Expansion focused on one town may raise concerns about whether state resources are being fairly distributed across regions, potentially disadvantaging other communities seeking economic development
  • Environmental and infrastructure impact: Rapid growth in the bioscience sector could strain local infrastructure (utilities, transportation, housing) and require environmental review, particularly for laboratory facilities

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.